Otava presents a new cAMP dependent protein kinase (PKA) focused library with 1998 compounds.
This library has been created as a part of a joint project with Life Chemicals aimed at design of a large set of receptor-based sharp-focused libraries.
In the framework of this project, Life Chemicals provides its Collection of 300,000 compounds and subsequent chemical optimisation.
Otava provides its drug-like Green Collection (50,000 compounds) and also is responsible for molecular modeling tasks.
Otava supplies fine organic chemicals including unique building blocks for combinatorial organic synthesis.
We provide compound libraries for screening, custom synthesis, molecular modeling services, targeted compound libraries and protein kinase inhibitors, prescreened anticancer compounds.
It offers design and development of fluorescent probes, kits and reagents.
